After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, REGN falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $903.48 and fluctuated between $912.22 as its day high and $898.26 as its day low. The current market capitalization of Regeneron Pharmaceuticals, Inc. is $99.55B. A total of 0.59 million shares were traded on the day, compared to an average of 468.73K shares.
In the most recent transaction, McCourt Marion sold 250 shares of REGN for 964.73 per share on Apr 01 ’24. After the transaction, the EVP Commercial now owns 13,181 company shares. In a previous transaction on Apr 01 ’24, RYAN ARTHUR F sold 100 shares at 962.53 per share. REGN shares that Director owns now total 18,182.
Among the insiders who sold shares, MURPHY ANDREW J disposed of 5,783 shares on Mar 14 ’24 at a per-share price of $956.47. This resulted in the EVP Research holding 48,306 shares of REGN after the transaction. In another insider transaction, McCourt Marion sold 358 shares at $967.50 per share on Mar 01 ’24. Company shares held by the EVP Commercial now total 13,431.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, REGN has a high of $998.33 and a low of $684.80.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. REGN’s latest balance sheet shows that the firm has $5.69B in Cash & Short Term Investments as of fiscal 2021. There were $2.70B in debt and $3.93B in liabilities at the time. Its Book Value Per Share was $237.41, while its Total Shareholder’s Equity was $18.77B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REGN is Buy with a score of 4.44.
